Form D · Other
Vitavis Laboratories, Inc.
San Ramon, CA · CIK 0001617451
Offering snapshot reported Aug 22, 2014 · SEC filing
- Reported sold
- $342K Offering amount: $502K
- Investors reported
- 23 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 16, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 22, 2014 | Initial | $342,395 | No comparison | 23 | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-223444
Source: Form D, filed Aug 22, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Eric Freedland | Director |
| Stephen Kirnon | Director, Executive |
| Timothy Tigner | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
2603 Camino Ramon, Suite 200
San Ramon, CA, 94583
San Ramon, CA, 94583